| TTM
|
1/31/2026
|
1/31/2025
|
1/31/2024
|
1/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
834,241 | 738,182 | 593,410 | 471,800 | 355,426 |
|
Cost of Revenue
|
-281,157 | -242,525 | -183,191 | -147,527 | -115,818 |
|
Gross Profit
|
553,084 | 495,657 | 410,219 | 324,273 | 239,608 |
| Selling, General and Administrative Expenses
|
-484,032 | -473,271 | -398,409 | -349,102 | -290,455 |
|
Research and Development Expenses
|
-180,471 | -167,143 | -133,969 | -119,863 | -97,293 |
|
Operating Income/Expenses
|
-664,503 | -640,414 | -532,378 | -468,965 | -387,748 |
|
Total Operating Profit/Loss
|
-111,419 | -144,757 | -122,159 | -144,692 | -148,140 |
|
Other Income/Expense, Non-Operating
|
12,710 | 16,596 | 21,557 | 16,220 | 7,977 |
|
Non-Operating Income/Expenses, Total
|
12,710 | 16,596 | 21,557 | 16,220 | 7,977 |
|
Pretax Income
|
-98,709 | -128,161 | -100,602 | -128,472 | -140,163 |
|
Provision for Income Tax
|
-12,473 | -2,625 | -3,445 | -1,957 | -583 |
|
Net Income from Continuing Operations
|
-111,182 | -130,786 | -104,047 | -130,429 | -140,746 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-111,182 | -130,786 | -104,047 | -130,429 | -140,746 |
|
Non-Controlling/Minority Interests
|
-1,864 | -501 | 304 | 1,263 | 1,780 |
|
Net Income after Non-Controlling/Minority Interests
|
-113,046 | -131,287 | -103,743 | -129,166 | -138,966 |
|
Net Income Available to Common Stockholders
|
-113,046 | -131,287 | -103,743 | -129,166 | -138,966 |
|
Diluted Net Income Available to Common Stockholders
|
-113,046 | -131,287 | -103,743 | -129,166 | -138,966 |
| Basic EPS
|
-1.03 | -1.22 | -1.02 | -1.32 | -1.47 |
| Diluted EPS
|
-1.03 | -1.22 | -1.02 | -1.32 | -1.47 |
|
Basic Weighted Average Shares Outstanding
|
110,491 | 107,906 | 102,189 | 98,096 | 94,569 |
|
Diluted Weighted Average Shares Outstanding
|
110,491 | 107,906 | 102,189 | 98,096 | 94,569 |
|
Reported Normalized Basic EPS
|
0.45 | 0.39 | 0.18 | -0.25 | -0.64 |
|
Reported Normalized Diluted EPS
|
0.45 | 0.38 | 0.17 | -0.25 | -0.64 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-101,688 | -128,161 | -100,602 | -128,472 | -140,163 |
|
EBITDA
|
-77,166 | -108,833 | -90,487 | -121,509 | -135,545 |
|
Normalized EBITDA
|
69,751 | 34,912 | 24,108 | -23,671 | -61,656 |
|
Normalized Income
|
50,390 | 41,934 | 18,373 | -24,401 | -60,370 |
|
Total Unusual Items
|
146,917 | 143,745 | 114,595 | 97,838 | 73,889 |
|
Total Unusual Items Excluding Goodwill
|
146,917 | 143,745 | 114,595 | 97,838 | 73,889 |
1/31/2023 - 11/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade